3 rd CHART-CCAS-CMLF Joint Meeting 11 TH CCAS HIV/AIDS INTERNATIONAL WORKSHOP

Transcription

1 11 TH CCAS HIV/AIDS INTERNATIONAL WORKSHOP SONESTA MAHO BEACH RESORT ST. MAARTEN AUGUST 24 TH - 28 TH 2014 PREVENTION BENEFITS OF ANTIRETROVIRAL THERAPY IN CARIBBEAN HIV PATIENTS: THE CENTRAL ROLE OF PATIENT ENGAGEMENT IN THE CONTINUUM OF CARE

2 The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC) is a rapidly expanding alliance of over 220 international companies dedicated to combating the HIV/AIDS global epidemic using the business sector s unique skills and expertise. To learn more, please visit Partners in business combating HIV/AIDS More than 33 million men, women and children are believed to be living with HIV, with 2.7 million new infections occurring each year. Last year alone, almost 2 million people lost their lives to AIDS. 1 The GBC believes a strong coalition of companies worldwide is the best weapon against this epidemic as it strives to achieve the goals of advocacy, education and policy change. A proud member of the GBC, BD supports these objectives in the war against HIV/AIDS, and is privileged to contribute to the GBC s efforts to recruit new members and to find better ways to deliver precise solutions. Named one of the World s Most Admired Companies 2 as well as one of the World s Most Ethical Companies, 3 BD provides advanced medical technology to serve the global community s greatest needs. BD Helping all people live healthy lives. 1 UNAIDS, 2009 AIDS Epidemic Update, 2 FORTUNE Magazine, March 2014, 3 Ethisphere Institute, April 2013 Please visit BD and BD Logo are trademarks of Becton, Dickinson and Company BD

3 3 rd CHART-CCAS-CMLF JOINT MEETING INDEX SUNDAY 24 TH AUGUST Registration am 5.00 pm Opening Ceremony 6.30 pm pm MONDAY 25 TH AUGUST Immunology and Virological Suppression PLENARY SESSION: Immune system in HIV PLENARY SESSION: Virological suppression and the continuum of care TUESDAY 26 TH AUGUST Role of Laboratory and Laboratory Networks in the Continuum of Care PLENARY SESSION: Current and evolving issues impacting on Regional Laboratory Services PLENARY SESSION: Developing Regional Laboratory Networks BREAKOUT SESSIONS: Treatment as Prevention in practice Managing laboratory data for surveillance and improved patient care Industry Talks WEDNESDAY 27 TH AUGUST Caribbean Country Reports BREAKOUT SESSIONS: Breaking down the barriers to care M&E for Building Network Capacity Updates on Regional and Policy Initiatives THURSDAY 28 TH AUGUST Benefits and controversies of early antiretroviral therapy PLENARY SESSION: Research in Latin America and the Caribbean CLOSING REMARKS THANK YOU TO ALL OUR SPONSORS GOLD SILVER a Sysmex Company 1

4 IN MEMORIAM Joep Lange was the Professor of Medicine, Head of the Department of Global Health, at the Academic Medical Center (AMC), University of Amsterdam, Executive Scientific Director of the Amsterdam Institute for Global Health and Development (AIGHD), and Chair of the Steering Committee AIGHD. Joep Lange had been involved in HIV research and treatment since He was the architect and principal investigator of several pivotal trials on antiretroviral therapy and on the prevention of mother-to-child transmission of HIV in both the developed and developing world. In addition to various positions at the AMC, he was Chief of Clinical Research and Drug Development at the Global Programme on AIDS of the World Health Organization in Geneva from 1992 to From he was President of the International AIDS Society. He served on numerous advisory boards for both private and public sector organisations, including the Strategic and Technical Advisory Committee of the WHO HIV Department, the External Advisory Committee of the US HIV Vaccine Trials Network and the International Advisory Board of the Institute for Global Health of Imperial College. He also served as the Chairman of the PharmAccess Foundation (which he founded) and as Scientific Advisor to the Board of the Health Insurance Fund Foundation, which pioneers mechanisms of sustainable financing of health care in resource-poor settings. He was a member of the Supervisory Board of KNCV Tuberculosis Foundation. Joep Lange founded and was Editor-in-Chief of the journal Antiviral Therapy and served on several other editorial boards of scientific journals. He published more than 350 papers in peer-reviewed journals and guided more than 30 PhD students. In 2007 he was awarded the Eijkman Medal for his achievements in Tropical Medicine and International Health. The workshop organizers and Caribbean HIV community mourn the loss of Dr. Joep Lange who died on July 17 th 2014 in the Malaysian Airlines tragedy over Ukraine. We offer our condolences to his family and friends, while extending our gratitude to Eric van Gorp for delivering the Distinguished Lecture and Tribute to Dr. Lange and his life s work. 2

5 W E L C O M E Hon. Minister of Health Cornelius de Weever Ministry of Health, St.Maarten I am extremely honored as Minister of Public Health Social Development & Labor to welcome you to our shores as you participate in the third joint CHART-CCAS-CMLF Meeting and the 11 th annual CCAS HIV Workshop; moreover I am very pleased that our ministry could have assisted in making the hosting of this event possible. Over the years St. Maarten has done much to bring awareness to the community about HIV/AIDS. We were very successful in bridging the private and public sector through our RED Campaign, which ran for four years with a different theme each year mainly targeting the private sector through business participation each month of the year. We have also been able to tackle the topic of discrimination in the workplace by enforcing an HIV/AIDS Workplace policy within government and at various private entities. I have noticed that the theme Prevention benefits of antiretroviral therapy in Caribbean HIV patients: the central role of patient engagement in the continuum of care has as focus developing a successful treatment and prevention program. The theme of the workshop has been and remains a point of attention for us here on St. Maarten. I would like to wish all attendees to the conference fruitful discussions, and remember to take advantage during your spare time of what our beautiful island has to offer. Welcome! 3

6 W E L C O M E Ms. Cheryl Larmonie CCAS Country Representative for St.Maarten It is a great honor for me to welcome all delegates and the other healthcare professionals to the 11 th CCAS Workshop and organized jointly for the 3 rd time by CHART-CCAS-CMLF. On behalf of the Government of St. Maarten and the local committee, we are pleased and proud to be hosting this annual HIV workshop in this beautiful and lovely all inclusive resort, Sonesta Maho Beach Resort & Casino. CCAS with the joint partner s organizations has played an important role in achieving success in HIV prevention, treatment counseling and care for the countries in the Caribbean. CCAS has provided the opportunity for the countries in the Caribbean to review and learn from each other s challenges and experiences. And CCAS also helps the countries to reflect on the achievements of other countries in the region. Each island provide their most recent data, showing the development of the country HIV status. The Caribbean countries demonstrate a strong commitment to share, and strive for a world free of new HIV infections, zero discrimination, and zero AIDS related deaths. This year theme is: Prevention benefits of antiretroviral therapy in the Caribbean HIV patients; the central role of patient engagement in the continuum of care. I would like to take this opportunity to express my sincere thanks to CCAS, CHART, CMLF and everybody else that I forgot to mention who was involved in organizing this workshop, I truly appreciate your dedication. Healthcare professionals come together to continue work on the success of the HIV joint meeting. The exchange of experience has become of vital importance between the Caribbean islands. We need to learn from each other. At the same time, it can be very fruitful to get to know people and experts from other countries. There will be possibilities to make closer contacts in the coffee breaks, at dinner and lunch and probably at a drink in the evening. I hope that you will use this chance. I trust that we will have a very productive and successful workshop. A warm welcome again to one and all on the friendly island, ST. MAARTEN 4

7 W E L C O M E Professor Brendan Bain Caribbean HIV/AIDS Regional Training Network (CHART) A warm welcome from the CHART Regional Coordinating Unit at the University of the West Indies (UWI-CHART) and from the rest of the CHART Network to participants at this year s CHART-CCAS-CMLF workshop. This is the sixth successive year of the CHART-CCAS partnership and the third time in a row that we are joining with CMLF. Congratulations to CCAS on its eleventh HIV laboratory workshop! As before, this year s meeting will provide timely updates for clinicians and laboratory personnel. It will also help to coalesce the efforts of individuals and small teams that work in relative isolation throughout the year and serve to advance the effort to roll back the HIV epidemic in the Caribbean. New ideas are often generated in this annual meeting and initiated at national and regional level. Examples of new initiatives that will be reported at this year s workshop are the OECS Viral Load referral network and the Virtual HIV Research Unit (VHRU): a public gateway for Caribbean HIV reports. Progress in building the capacity of Caribbean laboratories and in the development of a Caribbean laboratory network will be demonstrated during the workshop. Thanks are due to the Caribbean Office of the CDC Division of Global HIV and AIDS and CMLF for recent advances in this area. Dialogue between clinicians and laboratorians during the meeting will help participants to gain greater appreciation of the complementarity of these two areas of work. CHART welcomes Dr. Sharon Weissman and Dr. Helmut Albrecht from the Division of Infectious Diseases at the University of South Carolina School of Medicine (USCSOM) to the clinical section of the meeting. The link with USCSOM is part of a new partnership with UWI for establishment of a post-doctoral fellowship in Clinical Infectious Diseases. Funding for the partnership comes from the US President s Emergency Plan for AIDS Relief (PEPFAR) via a Twinning Grant from the Health Resources and Services Administration (HRSA) to the American International Health Alliance (AIHA). PEPFAR is also providing support to CHART via HRSA. The planning team is grateful to the Ministry of Health of Sint Maarten for hosting the workshop. Special thanks go to the international faculty, exhibitors and sponsors for their most valuable input. We all look forward to this valuable meeting. 5

8 W E L C O M E Professor Clive Landis Caribbean Cytometry and Analytical Society (CCAS) It gives me great pleasure to welcome participants to the third Joint CHART- CCAS-CMLF Meeting and the 11 th Annual CCAS HIV Workshop. These workshops have consistently promoted a unified training approach combining the best practices of clinical, laboratory and social care in order to extend quality HIV testing to all, encourage recruitment and retention of infected persons into care, and drive down community viral load. We are proud within our member societies to have adopted a collaborative approach that has foreshadowed the WHO Consolidated Guidelines issued in 2013 on the use of antiretroviral drugs for treating and preventing HIV infection. The Caribbean region has been praised by UNAIDS for overseeing a decline in mother to child transmission and new infections in adults, with treatment as prevention garnering most plaudits in achieving these gains. The theme Prevention benefits of antiretroviral therapy in Caribbean HIV patients: the central role of patient engagement in the continuum of care has been selected to drill down into further detail what constitutes a successful treatment and prevention program. It begins with an accessible HIV test capable of reaching our vulnerable populations, which faces the perennial challenge how to destigmatize the disease in our small island settings and to extend the necessary support to assist diagnosis and recruitment of positive persons into care. The next step in the continuum is to retain and monitor patients during care to stage antiretroviral therapy and treat coinfections. And finally, possibly the hardest step, is to provide the necessary social support to counsel effective drug adherence in our patients, thereby driving down HIV viral load and securing the full prevention benefits of antiretroviral therapy in our communities. Finally, I wish to express my sincerest gratitude to The Ministry of Health for their enthusiastic hosting of this year s training workshop. My appreciation is extended especially to Cheryl Larmonie, CCAS Regional Council Member for St. Maarten, and her local organizing committee, to our partner organizations CHART and CMLF, my CCAS workshop organizing committee, and the distinguished faculty. I am grateful to our diverse range of exhibitors & sponsors who have combined again to host a multi-vendor expo: the expo is always popular with our professional HIV caregivers to assist their informed choice of commercial options best suited to their individual country settings. And the final word to you, the participants: Thank you for attending and please do enjoy the holistic training program on offer. 6

9 W E L C O M E Ms. Valerie Wilson Caribbean Med Labs Foundation (CMLF) On behalf of the Caribbean Med Labs Foundation (CMLF), I join with CCAS, the CHART Network and the Ministry of Health of St. Maarten in welcoming you to the eleventh CCAS meeting and fourth joint meeting of the CCAS, PANCAP and CMLF partnership aimed at continued development of the regional HIV/AIDS laboratory network. Our sincere thanks to the Ministry of Health of St. Maarten for warmly welcoming us and hosting this meeting. It is a notable achievement in the fight against HIV/AIDS, that the theme of this year s meeting speaks to the role of the patient in the continuum of care, as we look at the prevention benefits of ART in Caribbean patients. Such a goal has become a reality in recent years because of advances in treatment options, as well as the proof from scientific studies that have shown the positive effects of ART treatment in prevention of spread of HIV infection. In this regard, laboratory services play a critical role, both internationally and here within the Caribbean, in providing proof of the undetectable viral loads that can be achieved when HIV infected persons are effectively treated with ART. The role of the laboratory in supporting the care of HIV patients at all stages, from identification of infected persons to monitoring of treatment and care is indisputable. As CMLF continues implementation of the PANCAP Global Fund Round 9 grant, in collaboration with Ministries of Health and our regional and international laboratory and clinical colleagues, we seek to positively impact on key issues related to the strengthening of laboratory networks, including monitoring of access and quality of laboratory services. During the laboratory network meeting we will review advances made in the laboratory networks within the region, and discuss the progress of key regional initiatives including CMLF s work with countries to establish national laboratory policies, the HIV-Syphilis Elimination programme led by PAHO/WHO, and the Laboratory Quality Management Systems Stepwise Improvement Process (LQMS-SIP) being led by the CARICOM Regional Organisation for Standards and Quality (CROSQ). We will also learn from the experience of the Dutch Antilles in their initiatives to improve laboratory quality and achieve accreditation. This meeting will undoubtedly continue the CCAS tradition of providing information on cutting edge and regionally appropriate approaches and technologies. We look forward to updates shared by our international colleagues and industry experts, to learning from our collective experiences within the region and internationally, and to continuing our work together in partnership with those affected, to improve the lives of HIV/AIDS patients within our region. 7

10 SUNDAY 24 TH AUGUST REGISTRATION AND OPENING CEREMONY REGISTRATION AM 5.00 PM OPENING CEREMONY 6.30 PM PM, Master of Ceremonies: TBA 6.30 pm National Anthem of St. Maarten 6.35 pm Opening Prayer TBA 6.40 pm Welcome: Clive Landis, Caribbean Cytometry & Analytical Society 6.50 pm Greetings: Excellency. Mr. V.H. Cornelius de Weever, Minister of Public Health, Social Development and Labor, Government of Sint Maarten 7.05 pm Greetings: Excellency Ms. Aline Henson, President of the Collectivité, Saint Martin 7.20 pm CCAS Distinguished Lecture and Tribute to Joep Lange: Eric van Gorp, Erasmus MC, Netherlands 7.50 pm Vote of Thanks: Brendan Bain, Caribbean HIV AIDS Regional Training (CHART) Network 8.00 pm Entertainment / Snacks / Drinks MONDAY 25 TH AUGUST IMMUNOLOGY AND VIROLOGICAL SUPPRESSION PLENARY SESSION: IMMUNE SYSTEM IN HIV CHAIR: Brendan Bain 8.30 am Innate and Adaptive Immunity Kim Quimby, University of the West Indies, Barbados 9.45 am How the Normal Immune Response breaks down in HIV/AIDS Kim Quimby Coffee break am PLENARY SESSION: IMMUNE SYSTEM IN HIV CHAIR: Clive Landis am Immunology Q & A and Infectious Disease Case Histories Kathy Shupe, Kim Quimby, Eric van Gorp Lunch pm 8

11 MONDAY 25 TH AUGUST continued IMMUNOLOGY AND VIROLOGICAL SUPPRESSION PLENARY SESSION: VIROLOGICAL SUPPRESSION AND THE CONTINUUM OF CARE CHAIR: Mo O Gorman 1.30 pm Antiretrovirals for HIV Prevention Wayne Duffus, CDC, USA, Joep Lange 2.15 pm When to start antiretroviral treatment? Sharon Weissman, Director, Division of Infectious Diseases, University of South Carolina School of Medicine, Columbia, South Carolina Coffee break pm CHAIR: Kim Quimby 3.30 pm The 2013 Consolidated WHO guidelines: Implications for adults and children across the continuum of HIV care Mo O Gorman, University of Southern California and the Children s Hospital of Los Angeles 4.15 pm CCAS EGM Agenda: Selecting Host Country for 2015 TUESDAY 26 TH AUGUST ROLE OF LABORATORY AND LABORATORY NETWORKS IN THE CONTINUUM OF CARE PLENARY SESSION: CURRENT AND EVOLVING ISSUES IMPACTING ON REGIONAL LABORATORY SERVICES CHAIR: Marquita Gittens-St. Hilaire 8.30 am CDC-APHL Updated Guidelines for HIV Diagnostic Testing Bernard Branston, CDC, USA 9.00 am Undetectable now what? Helmut Albrecht, University of South Carolina, USA 9.30 am The Importance of the HIV Treatment Cascade Paul Edwards, PHCO Trinidad and Tobago am Viral load as an M&E tool to strengthen national HIV programs across the network Clive Landis, CCAS Coffee break am 9

12 TUESDAY 26 TH AUGUST continued PLENARY SESSION: DEVELOPING REGIONAL LABORATORY NETWORKS CHAIR: Robert Wever am Co-ordination of Regional Laboratory Network CARPHA s role Cristina Gutierrez, CARPHA am Panel Discussion: WHO Treatment Guidelines 2013 implications for patient care and treatment Bernard Branson, Clive Anderson, Valerie Wilson, Lynette Hardy Lunch pm BREAKOUT SESSIONS pm GROUP 1 CHAIR: Kim Quimby GROUP 2 OLD AND NEW APPROACHES IN HIV CARE AND TREATMENT 1.15 pm The TB/HIV Challenge after guidelines, what? Brendan Bain 2.15 pm Twinning - a partnership for strengthening Infectious Disease Training Sharon Weissman, Brendan Bain Coffee break pm MANAGING LABORATORY DATA FOR SURVEILLANCE AND IMPROVED PATIENT CARE CHAIR: CMLF designate 1.15 pm Improving Test Utilization Robert Wever, Aruba 1.45 pm Using Lab and Health Information Systems to support patient care and surveillance Wayne Labastide, CMLF 2.15 pm Using Laboratory Information System to improve patient care and surveillance Walter Jones, Dominica 2.45 pm Exporting Lab Data to the National Health Information System Elliot Samuel, St. Vincent Coffee break pm PLENARY SESSION: INDUSTRY TALKS CHAIR: Mo O Gorman 3.45 pm Title Beckton Dickinson 4.00 pm HIV Diagnostic, Staging, Monitoring and Opportunistic Infectious Detection: The total solution Alere 4.15 pm Load and Go Beckman Coulter 4.30 pm Partec Essential Healthcare - Partec 4.45 pm Innovation and Flexibility through the cobas 4800 System Roche Diagnostics 10

13 WEDNESDAY 27 TH AUGUST LABORATORY QMS AND M&E IN A CHANGING TREATMENT PARADIGM CARIBBEAN COUNTRY REPORTS 8.30 am CHAIR: Wendy Kitson-Piggott Coffee break am CARIBBEAN COUNTRY REPORTS continued am CHAIR: Valerie Wilson Lunch pm BREAKOUT SESSIONS pm GROUP 1 CHAIR: Clive Anderson CHAIR: Brendan Bain GROUP 2 CHAIR: TBA Breaking down the barriers to care 1.30 pm VCT by the St. Maarten AIDS Foundation, an overview of data from counseling Gerard van Osch 2.00 pm Text messaging to reach persons who were lost to follow-up TBA 2.30 pm Retaining HIV-infected pregnant women in post-partum care, Guyana Mallika Mootoo Coffee break pm 3.30 pm Working to reduce stigma & discrimination through interactive trigger tapes Clive Anderson, CHART, Jamaica 4.00 pm Psychosocial curriculum implementation a progress report - Denise Minott, Jamaica 4.00 pm Quality Improvement andthe HIV treatment and care cascade Clive Anderson M&E for Building Network Capacity pm M&E system for tracking Caribbean Network Performance Wendy Kitson-Piggott, CMLF 1.50 pm Achievements in Accreditation in the Dutch speaking Caribbean Nasser Ajubi, St. Maarten and Robert Wever, Aruba 2.20 pm Role of the Inspectorate in ensuring quality of health services Earl Best, St. Maarten 2.40 pm Progress in implementation of the LQMS-SIP towards Accreditation in the Caribbean Claire Durant, CROSQ, Barbados Coffee break pm 11

14 WEDNESDAY 27 TH AUGUST continued BREAKOUT SESSIONS pm continued GROUP 2 CHAIR: Walter Jones UPDATES ON REGIONAL AND POLICY INITIATIVES 3.30 pm Regional Framework for National Laboratory Policy Development Valerie Wilson, CMLF 4.00 pm Developing a National Laboratory Policy TBA, Belize 4.30 pm Elimination of HIV and Syphilis implications for laboratory services Paul Edwards, PHCO, Trinidad & Tobago SOCIAL NIGHT, venue TBA 6.30 pm THURSDAY 28 TH AUGUST BENEFITS AND CONTROVERSIES OF EARLY ANTIRETROVIRAL THERAPY PLENARY SESSION: RESEARCH IN LATIN AMERICA AND THE CARIBBEAN CHAIR: CHART designate 8.30 am Five Year HIV Viral Load Trends in OECS Countries Utilizing the Ladymeade Reference Unit Laboratory Referral Service in Barbados Kelly Carmichael-Simmons 8.50 am Jamaica Quality Improvement Collaborative ( JaQIC!) Clive Anderson 9.10 am Exploring the reproductive decision making process of HIV positive women in County Victoria, Trinidad and Tobago Erica Joseph 9.30 am Successes and Challenges of HIV/AIDS treatment from 2002 to Present in Barbados Rosamund Lovell 9.50 am The Financial Impact of Provider Initiated HIV Counseling and Testing Policies at Davis Memorial Hospital and Clinic, Georgetown Guyana Adele Mack am HIV Gateway: enhancing access to Caribbean HIV research via a public website Caroline Allen Coffee break am 12 1

15 THURSDAY 28 TH AUGUST continued PLENARY SESSION: RESEARCH IN LATIN AMERICA AND THE CARIBBEAN continued CHAIR: Brendan Bain am HIV resistance Charles Boucher, Erasmus MC, Netherlands am INTERREG Cyril Clavel, Unité de Dépistage et Soins des Maladies Transmissibles, Centre Hospitalier Louis-Constant Fleming pm Special considerations for Women and HIV Tamara Thompson, Consultant Physician, University Hospital of the West Indies, Mona, Kingston, Jamaica Lunch pm PLENARY SESSION: CHAIR: CHART designate 1.30 pm Living a long life with HIV: quality of life and economic considerations Eric van Gorp, Erasmus MC, Netherlands 2.00 pm Leadership development and the Caribbean HIV Response:-A Retrospective on CHLI Maxine Ruddock-Small, Caribbean Health Leadership Insitute, Jamaica 2.30 pm From Care To Cure in HIV Treatment Charles Boucher, Joep Lange CLOSING REMARKS VALERIE WILSON 13

16 NOTES 14

17 Dedicated Solutions for Improving Patient Care in Adults and Children a Sysmex Company Accurate, Affordable, Portable CyFlow minipoc CyFlow Counter Reagents and Consumables CyScopes Mobile/Point-of-care CD4 and CD4% counter for routine HIV immune status monitoring and follow-up diagnostics of adult and pediatric AIDS patients. Dedicated CD4 and CD4% counter for routine HIV immune status monitoring and follow-up diagnostics of adult and pediatric AIDS patients. The optional Autopreparation and Autoloading Station adds the capability to fully automate sample preparation for CD4 analysis and automated sample loading to the CyFlow Counter. Dry MAb reagents, standards, biological and non-biological control materials for QC/EQA, sheath fluids, cleaning and decontamination solutions and CellTrics Disposable Filters for separation of cells and nuclei. Portable and battery-operated LED fluorescence and transmitted light microscopes for highest sensitivity TB or Malaria diagnostics. Optional CMOS camera module (USB connection) Not all products available in all countries. Sysmex America, Inc. All rights reserved. Sysmex America, Inc. 577 Aptakisic Road, Lincolnshire, IL 60069, U.S.A. Tel REGIONAL PARTNERS The virtual Caribbean Health Connection Join vchc to (vchc) is a free community of practice for Caribbean health professionals wishing to Consult on case connect on matters related to the prevention management and management of chronic diseases in the Engage with other region. health professionals Access a registry of regional health professionals Share events and resources SIGN UP NOW!

18 The cobas 4800 System features state-of-the-art, fully automated sample preparation combined with real-time PCR technology for amplification and detection, plus easy-to-use software that seamlessly integrates both components to maximize lab efficiency. The cobas 4800 System allows you to run the cobas 4800 HPV Test* including a high risk panel and 16/18 genotyping in the same workflow and the cobas 4800 CT/NG Test* featuring a double target CT test and the new generation NG test designed for high specificity. For more information on how the cobas 4800 System can bring you peace of mind, contact your local Roche Molecular Diagnostics representative GO25 = LOAD & Speed, Ease, & Efficiency only from Aquios CL The Aquios CL LOAD & GO flow cytometer from Beckman Coulter delivers the fast turnaround that busy clinical labs need to provide critical test results on the spot. Including sample prep, loading, and data analysis, it takes just 20 minutes to get your first result. After the first result, it s 25 results/hour for up to one full 96-well plate. With Aquios CL, you eliminate many workflow inefficiencies of existing systems and get fast results. See for yourself how the Aquios CL works. Aquios is: Pending submission and clearance by the United States Food and Drug Administration; not yet available for in vitro diagnostic use. The device has not yet been licensed in accordance with Canadian law The performance specifications of this product have not been established Les spécifications de rendement de l instrument n ont pas été établies

19

20 CCAS Professor Clive Landis - President and Head of Organising Committee Akinola Abayomi - Vice President Namrata Sippy-Chatrani - Executive Secretary -Treasurer Kim Quimby - Scientific Programme Development Officer Vera Layne - Public Relations Officer Andre Greenidge - Communications Officer Shauna Marshall - Country Representatives Lourdes Soriano Rouco - CCAS Committee Member Songee Beckles, Kelly Carmichael-Simmons, Kiana Hall - Committee Members CCAS CHART Professor Brendan Bain - Director, CHART Regional Coordinating Unit Dr. Carol-Ann Senah - Deputy Director, CHART Regional Coordinating Unit Dr. Clive Anderson - Clinical Coordinator, CHART Regional Coordinating Unit Ms. Sherie Cox - Programme Assistant, CHART Regional Coordinating Unit Ms. Jennifer Reid - Administrative Assistant, CHART Regional Coordinating Unit CMLF Ms. Valerie Wilson - Director Mrs. Wendy Kitson-Piggott - Laboratory Specialist Dr. Wayne Labastide - Laboratory Information Specialist Ms. Louise Mathura - Administrative Assistant LOCAL ORGANISING COMMITTEE Cheryl Larmonie - Lab technician, St Maarten Lab Services Juliana Lake-Carty - Lab technician, St Maarten Lab Services Margje Troost - St.Maarten Public Health department Maxsalia Lindeborg-Koek - St.Maarten Public Health department Yolaine Bruney - St.Maarten Public Health department Fenna Arnell - Head of St.Maarten Public Health Department Alissa Sunshine Rios - Ministry of Public Health, Social Development and Labor Staff Office 1